Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 6, Issue 10, pp. 1186-1198
PubMed
Published By
Print ISSN
Online ISSN
History
- Received February 7, 2018
- Revision received June 7, 2018
- Accepted August 9, 2018
- Published first August 14, 2018.
Article Versions
- Previous version (August 14, 2018 - 06:53).
- Previous version (August 31, 2018 - 06:58).
- You are viewing the most recent version of this article.
Copyright & Usage
©2018 American Association for Cancer Research.
Author Information
- Jinming Yang1,2,
- Amrendra Kumar1,3,
- Anna E. Vilgelm2,
- Sheau-Chiann Chen4,
- Gregory D. Ayers4,5,
- Sergey V. Novitskiy6,
- Sebastian Joyce1,3, and
- Ann Richmond1,2,*
- 1Tennessee Valley Healthcare System, Department of Veterans Affairs, Vanderbilt University Medical Center, Nashville, Tennessee.
- 2Department of Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee.
- 3Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee.
- 4Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee.
- 5Division of Cancer Biostatistics, Department of Biostatistics, Vanderbilt University, Nashville, Tennessee.
- 6Department of Medicine, Vanderbilt University, Nashville, Tennessee.
- ↵*Corresponding Author:
Ann Richmond, Vanderbilt University, PRB432, 2220 Pierce Avenue, Nashville, TN 37232. Phone: 615–343–7777; Fax: 615–936–2911; E-mail: ann.richmond{at}vanderbilt.edu
October 2018
Volume 6, Issue 10
Volume 6, Issue 10
Loss of CXCR4 in Myeloid Cells Enhances Antitumor Immunity and Reduces Melanoma Growth through NK Cell and FASL Mechanisms
Jump to section
Advertisement